Abstract
Most of the data accumulated to date on the immunoregulatory effects of prostaglandins (PG) on T cell activation stem from the archetypal inhibitory effect of PGE(2). In this study we provide instead, the first evidence that exogenous PGB(2), a catabolic metabolite of PGE(2), synergizes with signals delivered by T cell receptor (TCR) engagement to induce interleukin-2 (IL-2) production and IL-2 receptor (IL-2R) alpha-expression in Jurkat cells. Accordingly, PGB(2) enhances the proliferation of anti-CD3-activated peripheral blood lymphocytes (PBL). In terms of cellular signaling, we present evidence that PGB(2) activates tyrosine kinase activities and efficiently increases c-fos mRNA expression and nuclear factor-kappa B (NF-kappa B) translocation to the nucleus. Owing to these features, PGB(2) appears as a new lipid mediator capable of delivering an ancillary signal leading to T lymphocyte activation.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antigens, CD / metabolism
-
Antigens, Differentiation, T-Lymphocyte / metabolism
-
Cell Division / drug effects
-
Enzyme Activation / drug effects
-
Genes, fos / drug effects
-
Humans
-
In Vitro Techniques
-
Interleukin-2 / biosynthesis
-
Interleukin-2 / genetics
-
Jurkat Cells
-
Lectins, C-Type
-
Lymphocyte Activation / drug effects*
-
NF-kappa B / metabolism
-
Prostaglandins B / pharmacology*
-
Protein-Tyrosine Kinases / metabolism
-
RNA, Messenger / genetics
-
RNA, Messenger / metabolism
-
Receptors, Antigen, T-Cell / drug effects
-
Receptors, Antigen, T-Cell / metabolism
-
Receptors, Interleukin-2 / genetics
-
Receptors, Interleukin-2 / metabolism
-
Signal Transduction
-
T-Lymphocytes / cytology
-
T-Lymphocytes / drug effects*
-
T-Lymphocytes / immunology*
Substances
-
Antigens, CD
-
Antigens, Differentiation, T-Lymphocyte
-
CD69 antigen
-
Interleukin-2
-
Lectins, C-Type
-
NF-kappa B
-
Prostaglandins B
-
RNA, Messenger
-
Receptors, Antigen, T-Cell
-
Receptors, Interleukin-2
-
prostaglandin B2
-
Protein-Tyrosine Kinases